TRACON Pharmaceuticals, Inc. (TCON)
OTCMKTS: TCON · Delayed Price · USD
0.630
+0.029 (4.83%)
Jul 22, 2024, 9:41 AM EDT - Market open
TRACON Pharmaceuticals Stock Forecast
TCON's stock price has decreased by -89.72% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for TCON stock has a target of 60, which predicts an increase of 9,423.81% from the current stock price of 0.63.
Analyst Consensus: Hold
* Price targets were last updated on Aug 15, 2023.
Analyst Ratings
The average analyst rating for TCON stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $120 → $60 | Strong Buy | Maintains | $120 → $60 | +9,423.81% | Apr 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $140 → $120 | Strong Buy | Maintains | $140 → $120 | +18,947.62% | Mar 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +22,122.22% | Nov 20, 2023 |
| JonesTrading | JonesTrading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 21, 2023 |
Financial Forecast
Revenue This Year
n/a
from 12.05M
Revenue Next Year
1.19M
EPS This Year
-4.26
from -0.11
EPS Next Year
-2.92
from -4.26
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 3.7M | 41.3M | 83.0M | 135.1M |
| Avg | n/a | 1.2M | 24.7M | 73.2M | 125.8M |
| Low | n/a | n/a | 13.0M | 63.2M | 115.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 3,374.3% | 236.2% | 84.6% |
| Avg | - | - | 1,973.6% | 196.6% | 71.9% |
| Low | - | - | 995.3% | 156.1% | 58.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.44 | -1.26 | 1.02 |
| Avg | -4.26 | -2.92 | 0.04 |
| Low | -5.10 | -5.55 | -0.83 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.